Contents 1 Name 3 2 Commencement 3 3 Authority 3 4 Revocation 3 5 Application 3 6 3 7 Kind of injury, disease or death to which this Statement of Principles relates 3 8 Basis for determining the factors 4 9 Factors that must exist 4 10 Relationship to service 5 11 Factors referring to an injury or disease covered by another Statement of 5 Schedule 1 - Dictionary 6 1 6 Name This is the Statement of Principles concerning malignant neoplasm of the (No. 49 of 2016). urethra (Reasonable Hypothesis) Commencement This instrument commences on 23 May 2016. Authority This instrument is made under subsection 196B(2) of the Veterans’ Entitlements Act 1986. Revocation The Statement of Principles concerning malignant neoplasm of the urethra No. 1 of 2008, as amended, made under subsections 196B(2) and (8) of the VEA is revoked. Application This instrument applies to a claim to which section 120A of the VEA or section 338 of the Military Rehabilitation and Compensation Act 2004 applies.
Contents 1 Name 3 2 Commencement 3 3 Authority 3 4 Revocation 3 5 Application 3 6 3 7 Kind of injury, disease or death to which this Statement of Principles relates 3 8 Basis for determining the factors 4 9 Factors that must exist 4 10 Relationship to service 5 11 Factors referring to an injury or disease covered by another Statement of 5 Schedule 1 - Dictionary 6 1 6 Name This is the Statement of Principles concerning malignant neoplasm of the urethra (Reasonable Hypothesis) (No. 49 of 2016). Commencement This instrument commences on 23 May 2016. Authority This instrument is made under subsection 196B(2) of the Veterans’ Entitlements Act 1986. Revocation The Statement of Principles concerning malignant neoplasm of the urethra No. 1 of 2008, as amended, made under subsections 196B(2) and (8) of the VEA is revoked. Application This instrument applies to a claim to which section 120A of the VEA or section 338 of the Military Rehabilitation and Compensation Act 2004 applies.